Latest News from "The Pink Sheet" DAILY -- Merck Unveils Gardasil Data

Merck Looks To Mid-June FDA Decision On Expanded Use Of Gardasil To Older Women

Company unveils data at European conference supporting use in women ages 27 through 45; data was sent to FDA late last year.   read more

 

Academia May Find That Earlier Industry Partnering Entails Demands For Longer-Term Data Development, Woodcock Cautions

At NIH meeting on academic/industry partnerships, Woodcock also urges academic institutions to maintain commitments to developing enabling technologies.   read more

 

Genzyme Institutes Further Rationing Of Cerezyme, Fabrazyme To Build Inventory

Despite last year's manufacturing problems and the resulting shortages, biotech says 85 percent of U.S. Cerezyme patients have returned.   read more

 

Eleven Biotherapeutics Gets Rocking As Next Generation Biologics Firm

Proceeds from a $35 million Series A financing, led by Flagship Ventures and Third Rock Ventures, will be used to build R&D and business development teams.   read more

 

U.K. Nicotine Replacement Therapy Harm Reduction Indication Could Be Model For U.S.

MHRA's inclusion of harm reduction as an NRT indication could be applied to other smoking-cessation products in the U.K. and could sway FDA to grant GSK's petition and allow a wider variety of indications to maximize the public health benefit of using the products.   read more

 

"The Pink Sheet" DAILY - Daily, in-depth analysis of the key developments shaping the biopharma industry. Not a subscriber? To register for a free trial, click here